IP&C 2023 Preview
will provide an overview of C.difficile infection management and the IP&C challenges. He will consider what’s new and what remains the same. There will also be some alarming revelations on the enormous burden of gum diseases on society and individuals, using data from The Economist and the WHO. Iain Chapple director of research, Institute of Clinical Sciences, University of Birmingham, will show that severe gum disease is significantly associated with premature mortality and non-communicable diseases of ageing. He will use video animations to show the mechanisms through which severe gum disease is linked to type-2 diabetes and cardiovascular diseases. Jacky Edwards, a clinical lead for the National
Wound Care Strategy programme (NWCSP) will tackle the important issue of surgical site infection. The frequency and complexity of surgical wound complications are often under-estimated but surgical wounds are the most commonly managed wound type (57%) and delayed healing in surgical wounds is estimated to cost the National Health Service (NHS) £982.9 million per year. Reducing surgical wound complications could have a significant financial impact on NHS costs. However, there are challenges to such quality improvement work as we lack accurate information about the scale of the problem. She will point out that:
l Most surgical wound complications (SWCs) occur post discharge but most national surgical wound data collection ends on hospital discharge.
l To date, the focus has been on surgical site infections (SSIs) but not all surgical wound breakdown (dehiscence) is due to infection. l The impact of surgical wound breakdown,
whether or not associated with SSI, has a significant impact on quality of life for patients and NHS costs.
Therefore, there is an urgent need to broaden the scope of surveillance to focus on surgical wound complications, rather than the narrower focus on just surgical site infection. This presentation will therefore look at how the National Wound Care Strategy programme will develop a range of strategies to try and improve the prevention of surgical wound complications including: educational resources, updating the recommendations, patient resources and improvements in clinical data. Carole Hallam, an independent nurse consultant, will discuss a collaborative approach to prevent device related infections. The device related infection prevention practices (DRIPP) collaborative was set up in 2019, with the aim to support the spread and adoption of best practice to prevent device-related infections,
thereby improving outcomes for patients with urinary catheters and intravascular devices. The Infection Prevention Society – along with the National Infusion and Vascular Access Society (NIVAS), the British Association of Urology Nurses (BAUN), the Association for Continence Advice (ACA) and the Association of Safe Aseptic Practice (ASAP) – have produced a set of evidence-based resources for healthcare professions. The presentation will describe the journey for the development and testing of these resources and how they can be utilised to improve patient safety.
IP&C Innovation In addition to the conference programme, there will also be an exhibition showcasing solutions aimed at reducing healthcare-associated infections. Among the many sponsors include: Amity International, a specialist disinfectants manufacturer that continually pushes the boundaries of science within the disinfection market. The company produces state-of-the- art technologies to meet consumer demands, including a room disinfection range comprising: l Airdecon 200 – a hydrogen peroxide disinfection system, offering a greater than log 7 reduction against a wide range of pathogens.
l Airdecon UVC – a powerful UVC disinfection devices offering a quick room turnaround time.
l Airdecon Pure – an air purification system that filters down to 0.007 micron making it x42 more effective than HEPA filtration.
Baxter Healthcare/ICNET provides clinical surveillance software. The COVID-19 pandemic has presented even the most developed and efficient healthcare systems with unprecedented challenges as they have had to adapt quickly to manage its suppression. Now more than at any other time, technology is playing a crucial
36
www.clinicalservicesjournal.com I April 2023
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
